ArticlePloS one2025
To develop online platform and determine its effectiveness in ENHANCING DIABetes knowledge among diabetes patients in primary CARE clinic (Enhancing-Diab-Care Study): Study protocol.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Trial
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Diabetes Mellitus (DM)- Type 2 is increasingly prevalent in today's population. DM remains poorly controlled due to insufficient knowledge and understanding of this disease. Maintaining good diabetic self-care requires knowledge and empowerment. The COVID-19 pandemic had caused a shift of some public attention from non-communicable to communicable diseases, leading to patients becoming ignorant of their diabetic status. Therefore, we aim to develop an online education video platform that enables patients to enhance their knowledge about Diabetes Mellitus Type 2. In this blocked randomised control trial, a minimum number of 232 participants with type 2 diabetes mellitus will be needed. Patients will consent and voluntarily participate during their follow-up at public primary health care clinic (Klinik Keshihatan Cheras Baru). Patients undergoing diabetic follow-up will be divided into two groups where only patients within the intervention group will receive diabetic care video. Patients' clinical profiles such as date of birth, gender, education status, Diabetes Knowledge Test (DKT) and Diabetic Empowerment Scale (DES-28) were collected to assess diabetes self-care knowledge and empowerment using self-administered questionnaires. Patients will be reminded to complete the educational video at the 3-month and 6-month follow-ups, and the aforementioned parameters will be reassessed. The data will be assessed using an independent t-test for the difference between intervention and control groups. A Paired t-test will assess the difference between the patient pre and post-intervention after 6 months. A generalised Estimating Equation will be used to investigate the effectiveness of diabetes knowledge and clinical outcome, adjusted with covariates. P < 0.05 will be considered statistically significant. Ethical principles outlined in the Declaration of Helsinki and Malaysian Good Clinical Practice Guideline will be followed. Ethical approval will be obtained from MREC and NMRR before starting any study-related activities.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.